RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

Purpose: The aim of this study was to investigate time-dependent changes in erectile function and responsiveness to type 5 phosphodiesterase (PDE5) inhibitor in streptozotocin-induced diabetic rats.
Materials and Methods: Seventy-five 8-week-old male Sprague-Dawley rats were randomly divided into two groups: diabetic (n=50) and control (n=25). The diabetic group received a single intraperitoneal injection of streptozotocin. The diabetic rats and age-matched control rats underwent cavernosometry before and after administration of DA-8159 (a novel PDE5 inhibitor) at 6, 8, 10, 12, and 14 weeks after induction of diabetes. The erectile response elicited by electrical stimulation of the cavernous nerve (3 V, width 0.2 msec, duration 30 seconds) was measured at several frequencies (2.5, 5, 10, and 20 Hz). Intracavernous pressure (ICP) and mean arterial pressure (MAP) were continuously monitored. Comparisons were made for ICP/MAP and areas under the curve (AUC) corresponding to the duration of electrical stimulation. The AUC was also corrected by the MAP.
Results: Diabetic rats maintained normal erectile responses until 6 weeks after diabetic induction. Following 8 weeks of diabetes, the rats showed significantly lower ICP/MAP and AUC/MAP at higher frequencies of nerve stimulation, which were normalized to controls by administration of DA-8159. In contrast, both physiologic parameters were significantly decreased in the 10-week diabetic rats and ICP/MAP at 20 Hz stimulation frequency recovered only by injection of DA-8159. At more than 12 weeks of diabetes, the rats demonstrated severe deterioration of erectile function, which did not fully respond to PDE5 inhibitor.
Conclusions: Findings from this study indicate that impairment of erectile function is followed by decreased responsiveness to PDE5 inhibitor during the course of diabetes.

참고문헌 (Reference)

1 조민철, "당뇨병 백서에서 제5형 Phosphodiesterase 억제제의 지속 투여가 발기능에 미치는 영향" 대한남성과학회 25 (25): 7-7, 2007

2 Cellek S, "Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats" 52 : 2353-2362, 2003

3 Ueno N, "The effect of sildenafil on electrostimulation-induced erection in the rat model" 14 : 251-255, 2002

4 Benet AE, "The correlation between the new RigiScan plus software and the final diagnosis in the evaluation of erectile dysfunction" 156 : 1947-1950, 1996

5 Romeo JH, "Sexual function in men with diabetes type 2: association with glycemic control" 163 : 788-791, 2000

6 Foresta C, "Role of androgens in erectile function" 171 : 2358-2362, 2004

7 Bivalacqua TJ, "RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction" 101 : 9121-9126, 2004

8 Allard J, "Reflex penile erection in anesthetized mice: an exploratory study" 155 : 283-290, 2008

9 Vickers MA, "Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus" 14 : 466-471, 2002

10 Yu JY, "Penile erectile responses to electric stimulation are enhanced by a new phosphodiesterase type-5 inhibitor" 12 : 299-304, 2005